{
"NDC": {
"NDCCode": "70069-836-01",
"PackageDescription": "1 VIAL in 1 CARTON (70069-836-01) / 3.5 mL in 1 VIAL",
"NDC11Code": "70069-0836-01",
"ProductNDC": "70069-836",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Bortezomib",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Bortezomib",
"DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"RouteName": "INTRAVENOUS; SUBCUTANEOUS",
"StartMarketingDate": "20250429",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA211898",
"LabelerName": "Somerset Therapeutics LLC",
"SubstanceName": "BORTEZOMIB",
"StrengthNumber": "3.5",
"StrengthUnit": "mg/3.5mL",
"Pharm_Classes": "Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-05-12",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250429",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}